IDEXX Laboratories

IDEXX Laboratories Debt

The Debt of IDEXX Laboratories (IDXX) as of Nov 7, 2026 is 847.84 M USD. In the previous year, Debt was 867.57 M USD — a change of -2.27% (lower).

Debt

847.84 MUSD

YoY

-2.27%

Last updated:

In 2025, IDEXX Laboratories's total debt was 847.84 M USD, a -2.27% change from the 867.57 M USD total debt recorded in the previous year.

The IDEXX Laboratories Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
898.51 M USD
Jan 1, 2019
888.25 M USD
Jan 1, 2020
908.48 M USD
Jan 1, 2021
923.70 M USD
Jan 1, 2022
1.35 B USD
Jan 1, 2023
947.88 M USD
Jan 1, 2024
867.57 M USD
Jan 1, 2025
847.84 M USD
The IDEXX Laboratories Debt history
YEARDebtYoY
847.84 MUSD-2.27%
867.57 MUSD-8.47%
947.88 MUSD-29.70%
1.35 BUSD+45.97%
923.70 MUSD+1.68%
908.48 MUSD+2.28%
888.25 MUSD-1.14%
898.51 MUSD-22.17%
1.15 BUSD+3.97%
1.11 BUSD+3.49%
1.07 BUSD+19.35%
899.00 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

IDEXX Laboratories Stock analysis

What does IDEXX Laboratories do? The history of IDEXX Laboratories Inc began in 1983 when a research team from the University of Maine developed technology for the automatic analysis of animal blood. The first products were soon sold and the company grew rapidly. Today, IDEXX is a leading global provider of veterinary diagnostic and IT solutions, recognized by customers in over 175 countries. IDEXX's business model is based on innovation and a comprehensive understanding of the needs of veterinarians and their patients. The company offers a wide range of products and solutions that make the diagnosis and treatment of animal diseases easier and more reliable. These include tests and devices for blood analysis, urine and stool diagnostics, as well as imaging, infection control, and cancer diagnostics. The company has several divisions that focus on different aspects of veterinary diagnostics. IDEXX Diagnostics is the largest business segment, offering veterinary lab services, diagnostic tests, and software solutions. IDEXX Water is a company specializing in the analysis of water samples and monitoring of environmental conditions. IDEXX Livestock, the newest division of IDEXX, provides veterinary solutions for agricultural and livestock operations. Key products of IDEXX include tests for parasites, infections, diabetes, and kidney function. The company has also developed some innovative products, such as SNAP tests, which provide fast and accurate results and can perform tests for various pathogens simultaneously. IDEXX is also a company committed to sustainability. The IDEXX Foundation was established in 2013 and has since donated over $32 million to local and global projects that aim to protect animals and the environment. Overall, IDEXX Laboratories Inc is a company specialized in veterinary diagnostic and IT solutions to support veterinarians in treating animals. The wide range of solutions and products, as well as the commitment to sustainability, make the company an important player in the market for veterinary diagnostics. IDEXX Laboratories is one of the most popular companies on Eulerpool.

Debt Details

Understanding IDEXX Laboratories's Debt Structure

IDEXX Laboratories's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing IDEXX Laboratories's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to IDEXX Laboratories’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in IDEXX Laboratories’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about IDEXX Laboratories stock

Debt of IDEXX Laboratories is 847.84 M USD in 2025.

Debt of IDEXX Laboratories changed from 867.57 M USD to 847.84 M USD, representing a -2.27% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt IDEXX Laboratories since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's IDEXX Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — IDEXX Laboratories

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — IDEXX Laboratories